Raymond James Trust’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,256
Closed -$224K 1170
2021
Q4
$224K Sell
1,256
-10
-0.8% -$1.78K 0.01% 1048
2021
Q3
$224K Sell
1,266
-17
-1% -$2.82K 0.01% 1003
2021
Q2
$206K Sell
1,283
-984
-43% -$151K 0.01% 1051
2021
Q1
$339K Sell
2,267
-392
-15% -$47.5K 0.01% 768
2020
Q4
$263K Buy
+2,659
New +$266K 0.01% 827

Other funds holding CNXC

Raymond James Trust's CNXC Position: Q1 2022 in Review

Raymond James Trust sold out of Concentrix (CNXC) in Q1 2022, closing a stake of 1,256 shares — an estimated $224K sold.

Raymond James Trust first reported a position in CNXC in Q4 2020 and held it in 5 quarters. The position peaked at $339K in Q1 2021. 354 funds tracked by Wall St. Rank hold CNXC as of Q1 2022.

  • Raymond James Trust reported no remaining Concentrix position as of Q1 2022 after selling out during the quarter.
  • Raymond James Trust sold 1,256 Concentrix shares in Q1 2022, an estimated $224K.
  • Raymond James Trust first reported a position in Concentrix in Q4 2020 and held it in 5 quarters.
  • Raymond James Trust's Concentrix position peaked at $339K in Q1 2021.
  • 354 funds tracked by Wall St. Rank held Concentrix as of Q1 2022.

Based on Raymond James Trust's 13F filing for Q1 2022, filed 12 May 2022.